Jose Manuel Martinez Manzano

Dr. Jose Manuel Martinez Manzano

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Annals of Allergy, Asthma & Immunology
Verified
Journal Article
Closed access
JMJose Manuel Martinez Manzano
Jose Manuel Martinez Manzano
KLKevin Bryan Lo
Kevin Bryan Lo
GPGabriel Patarroyo-Aponte
Gabriel Patarroyo-Aponte
ZAZurab Azmaiparashvili
Zurab Azmaiparashvili

24 May 2023 in Respiratory Medicine
Verified
Journal Article
Closed access
OCOmar Cantu-Martinez
Omar Cantu-Martinez
JMJose Manuel Martinez Manzano
Jose Manuel Martinez Manzano
STSahana Tito
Sahana Tito
APAlexander Prendergast
Alexander Prendergast
SJSimone A. Jarrett
Simone A. Jarrett
GEGlenn Eiger
Glenn Eiger

1 February 2022 in Annals of Allergy, Asthma & Immunology
Verified
Journal Article
Closed access
JMJose Manuel Martinez Manzano
Jose Manuel Martinez Manzano
KLKevin Bryan Lo
Kevin Bryan Lo
SJSimone A. Jarrett
Simone A. Jarrett
BCBrenda Chiang
Brenda Chiang
ZAZurab Azmaiparashvili
Zurab Azmaiparashvili

1 April 2024 in Pulmonary Circulation
Verified
Journal Article
Open access
JMJose Manuel Martinez Manzano
Jose Manuel Martinez Manzano
APAlexander Prendergast
Alexander Prendergast
TJTara John
Tara John
RLRaul Leguizamon
Raul Leguizamon
IMIan McLaren
Ian McLaren
CWChristian Witzke
Christian Witzke
Pulmonary hypertension (PH) is associated with adverse outcomes in chronic kidney disease (CKD) patients. Our study suggests mildly elevated pulmonary vascular resistance ( > 2 to ≤ 3) is independently associated with major adverse cardiovascular events at 1‐year follow‐up. Early diagnosis of precapillary PH in CKD patients can potentially improve clinical outcomes.

14 June 2022 in Toxicology Communications
Verified
Journal Article
Open access
JMJose Manuel Martinez Manzano
Jose Manuel Martinez Manzano
KEKarim O. Elkholy
Karim O. Elkholy
KLKevin Bryan Lo
Kevin Bryan Lo
Ethylene glycol (EG) is a toxic alcohol that causes central nervous system depression and multiple metabolic abnormalities including a high anion gap metabolic acidosis (HAGMA), elevated osmolal gap (OG), and acute kidney injury. Few case reports of EG intoxication report brain MRI findings. We describe an elderly female who was brought to the hospital because of altered mentation. We diagnosed her with EG toxicity and treated with fomepizole based on metabolic abnormalities and presence of urine calcium oxalate crystals. Our patient’s brain MRI showed T2-hyperintense signals located in the midbrain, hippocampi, basal nuclei, and thalami consistent with previous MRI reports with confirmed EG toxicity. As in this case, a clear history of poisoning is not always available. However, antidote therapy with alcohol dehydrogenase blockade should be initiated if clinical data suggests EG intoxication. Our patient’s EG concentration returned elevated two days after admission blood draw confirming the initial diagnosis. MRI of the brain may add diagnostic support to laboratory findings while awaiting a definitive EG concentration.

1 December 2021 in Annals of Allergy, Asthma & Immunology
Verified
Journal Article
Closed access
JMJose Manuel Martinez Manzano
Jose Manuel Martinez Manzano
KLKevin Bryan Lo
Kevin Bryan Lo
SJSimone A. Jarrett
Simone A. Jarrett
BCBrenda Chiang
Brenda Chiang
EQEduardo Quintero
Eduardo Quintero
GPGabriel Patarroyo-Aponte
Gabriel Patarroyo-Aponte